Nicholas is an entrepreneur with a track record in the financial services and the pharmaceutical industry.
He is the CEO of emaginal AG, a Swiss technology start up which he co-founded in order to combine technology and fitness, two subjects he is passionate about. In his past experience as Foreign Markets Director at Intersec, he played a key role in the expansion of this department and provided alternative investment options during the financial crisis. As a Health Outcomes manager at GlaxoSmithKline UK, he focused on Work Productivity analysis for patients suffering form Alzheimer's disease.
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
